Your SlideShare is downloading. ×
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Lind.doc
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
274
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. CURRICULUM VITAE David Scott Lind, M.D. Name: David Scott Lind MD MCG Rank: Professor Department of Surgery Medical College of Georgia Augusta, Georgia MCG Title: Chief, Section of Surgical Oncology Department of Surgery Medical College of Georgia Augusta, Georgia Office Address: BB-4514 Section of Surgical Oncology Department of Surgery Medical College of Georgia Augusta, Georgia 30912 Office Telephone: (706) 721-4726 FAX: (706) 721-9136 Email: dlind@mcg.edu PERSONAL Date/Place of Birth: November 26, 1958 Rochester, Minnesota Citizenship: U.S.A. Marital Status: Married: Barbara Kaplan Lind Son: Jason Daughters: Joanna, Jenny Education: 1977-1981 Hons Bsc., McMaster University, Hamilton, Ontario, Canada (Biology) 1981.1984 M.D. Eastern Virginia Medical School, Norfolk, Virginia 1984-1985 Internship (General Surgery), University of Texas at San Antonio, San Antonio, Texas 1985.1989 Residency (General Surgery), University of Texas at San Antonio, 1
  • 2. CURRICULUM VITAE David Scott Lind, M.D. San Antonio, Texas 1989.1992 Fellowship (Surgical Oncology), Medical College of Virginia, Richmond, Virginia Academic Appointments: Professor, Department of Surgery Medical College of Georgia April 2005 - Present Professor, Department of Surgery University of Florida College of Medicine August 2000 – April 2005 Assistant Professor, Department of Surgery University of Florida College of Medicine July 1992 - July 1997 Chief of General Surgery Gainesville VA Hospital July 1999 – August 2004 Chief, Surgical Service North Florida South Georgia VA System October 2000 - present Certification: The American Board of Surgery, 1990 Re-certification completed October 2000 Academic Positions: Administrative Chief Resident, University of Texas at San Antonio, 1988–1989 Member, Clinical Research Review Committee, Medical College of Virginia, 1989–1992 Instructor, Biochemistry 5204 Clinical Correlation Course and Microbiology Problem–Based Learning Course, 1992–Present Cancer Liaison Physician, Commission on Cancer, American College of Surgeons, University of Florida, 1993–1997 Chair, Committee on Cancer, University of Florida, 1998–Jan 2001 Member, Clinical Affairs Committee, University of Florida Cancer Center, Jan 2001 2
  • 3. CURRICULUM VITAE David Scott Lind, M.D. Member, Strategic Planning Group, Shands Hospital, October 2003 Member, Program Committee Association for Academic Surgery, 1995–1997 Member, Committee on Education, Association for Academic Surgery, 1997–1999 Member, Local Arrangements Committee, Society of Surgical Oncology, 1998 Member, Clinical Affairs Committee, Society of Surgical Oncology, 1998–2001 Member, Issues Committee, Society of Surgical Oncology, 2000-2002 Chairman, Clinical Affairs Committee, Society of Surgical Oncology, 2000-2002 Member, Board of Directors, Florida Surgical Society, 2001-present Program Coordinator, Florida Surgical Society Meeting, Orlando, Florida, June 2003 Program Coordinator, Florida Surgical Society Meeting, Key West, Florida, June 2004 Chairman, Specialty Council, North Florida South Georgia VA Health Care System, Jan 2003 – present Co-Coordinater, Advanced Clinic Access Retreat, North Florida South Georgia VA Health Care System, 2003 Chairman, Operative and Invasive Committee, North Florida South Georgia VA Health Care System, Jan 2003 – present 3
  • 4. CURRICULUM VITAE David Scott Lind, M.D. Cancer Liaison Physician, Commission on Cancer, American College of Surgeons, North Florida South Georgia VA Health Care System, July 2004 - present Member, Committee on Cancer, North Florida South Georgia VA Health Care System, July 2004 - present Member, Promotion and Tenure Committee University of Florida College of Medicine June 2004 - present Editorial Boards: Journal of Surgical Oncology, 1998–Present Breast Journal, 2000–Present Reviewer, Annals of Surgical Oncology Reviewer, Cancer Reviewer, Breast Diseases Honors and Awards: Graduated Cum Laude, Eastern Virginia Medical School, Norfolk, VA Top 5% of Class (No Alpha Omega Alpha Chapter), Eastern Virginia Medical School, Norfolk, VA Best Fellow Award, Medical College of Virginia, Richmond,VA, 1992 Outstanding Faculty Award, University of Florida, Gainesville, FL, 1994 & 1999 Lester R. Dragstedt Physician–Scientist Award, University of Florida, Gainesville, FL, 1994 Nominee, Hippocratic Award, University of Florida, Gainesville, Florida, 1997 & 1998 Elected Advisor to University of Florida, Class of 1999 Residents as Teachers Course Award 2002 Physician of the Year – Veterans of Foreign Wars 2003 4
  • 5. CURRICULUM VITAE David Scott Lind, M.D. Nomination to Society of Teaching Scholars University of Florida College of Medicine, Fall 2003 Exemplary Teacher Award, University of Florida College of Medicine, March 2004 Educational Activities: Finalist, Teaching Incentive Program, 1996 Student Clerkship Coordinator, Surgery 6 rotation 3rd & 4th year medical students, 1994 -1998 Director of the OSCE for the Third Year Surgery Rotation, 1998 - 2000 Surgery Interest Group Coordinator, 1996 – July 2003 Completed Surgeons as Educators Workshop, Atlanta, GA, 1997 Awarded Association for Surgical Education Fellowship (SERF) 1999 Member, Curriculum Committee University of Florida 1999 to present Nominated to Society of Teaching Scholars University of Florida, October 2000 Surgery Clerkship Director, University of Florida, 2000-July 2003 Selected to Masters in Medical Education Course, University of Florida, 2001 Associate Examiner, American Board of Surgery Certifying Examination, Jacksonville, FL, December 2001 VA Residency Program Coordinator Department of Surgery, January 2002 Associate Program Director, General Surgery Program, University of Florida, July 2003 - present Chairman, Education Committee, Department of Surgery, 5
  • 6. CURRICULUM VITAE David Scott Lind, M.D. University of Florida, July 2003 - present National Board of Medical Examiners (NBME) Step 2 Clinical Skills Examination Committee, July 2004 - present National Board of Medical Examiners (NBME) Step 2 Surgery Test Committee, July 2004 – present Facilitator Residents as Educators Curriculum Office for Program and Faculty Development University of Florida College of Medicine Research Awards: Existing Support Educational Grants Title: The Use of a Simulation-Based Training Program to Shorten Wait Times for Lower GI Tract Endoscopies and Improve Patient Outcomes In the North Florida South Georgia VA Health System Time Commitment: Principal Investigator (5%) Supporting Agency: North Florida Foundation for Research and Education (NFREE) Duration: One Year Level of Funding: $50,000 Title: A Pilot Study to Examine the Use of a Virtual Patient and Instructor in Teaching Medical Students Communication Skills using an Abdominal Pain Scenario Time Commitment: Principal Investigator (5%) Supporting Agency: University of Florida College of Medicine Educational (COMEC) Grant Duration: One Year Level of Funding: $5,000 Pending Support Educational Grants Title: The Use of Interactive Virtual Characters as Standardized Patients Time Commitment: Principal Investigator (10%) Supporting Agency: Stemmler Grant National Board of Medical Examiners (NBME) 6
  • 7. CURRICULUM VITAE David Scott Lind, M.D. Duration: 2 years Level of Funding: $70,000 Title: The Use of Virtual Patients to Teach Communication Skills Time Commitment: Principal Investigator (5%) Supporting Agency: Medical College of Georgia Combined Intramural Grant Program Duration: 1 years Level of Funding: $15,000 Title: Interactive Virtual Characters for Medical Diagnosis Training Time Commitment: Co-Principal Investigator (10%) Supporting Agency: National Science Foundation Information Technology Research Program Duration: 5 years Level of Funding: $500,000 Title: The Use of a Laparoscopic Simulator to Reduce Operative Times and Complication Rates for Laparoscopic Cholecystectomy at the University of Florida. Time Commitment: Principal Investigator (5%) Supporting Agency: Shands Hospital Duration: Pending Funding Level of Funding: $25,000 Previous Support Basic Science Grants Title: The Regulation of Glutamine Metabolism During Endotoxemia Time Commitment: 20% Supporting Agency: VA Merit Review Duration: Three years (Completed June 1993) Level of Funding: $150,000 (50,000 per year) Title: The Regulation of Arginine Transport by Pulmonary Artery Endothelial Cells Time Commitment: 10% Supporting Agency: University of Florida Division of Sponsored Research Award Duration: One year (Completed December 1994) Level of Funding: $7,500 Title: The Effect of Arginine-Enhanced Enteral Nutrition on Tumor/Host Characteristics in Hosts Bearing Nitric-Oxide Producing Tumors Time Commitment: 5% Supporting Agency: Sandoz Nutrition Corporation Duration: One year (beginning June 1997; extended to June, 1999) Level of Funding: $10,000 7
  • 8. CURRICULUM VITAE David Scott Lind, M.D. Clinical Grants Title: The Sunbelt Melanoma Project Time Commitment: Institutional Principal Investigator Supporting Agency: Schering Plough Corporation Duration: January, 1998 – Jan 2002: Multi-institutional trial of adjuvant interferon- α2b for melanoma patients with early nodal metastases detected by sentinel node biopsy. Level of Funding: $1,200 per patient enrolled Title: A Randomized Trial of Active Immunotherapy with a Polyvalent Melanoma –like Vaccine versus Biotherapy with Interferon alpha 2b for Melanoma Patients. Time Commitment: May 1999 – Present, Supporting Agency: John Wayne Cancer Institute Level of Funding: $3,500 per patient enrolled Title: Phase III Multi-Center Clinical Trial -The Comparison of Current Diagnostic Modalities to the Radioimmunoguided Surgery (RIGS- Neoprobe Corp.) System for Patients with Adenocarcinoma of the Colorectum Time Commitment: 2% Supporting Agency: National Cancer Institute Duration: One year (1994-1995) Level of Funding: Contract on Per Patient Enrollment Basis ($1500 per pt.) Title: Current Practice Patterns for the Use of Stereotactic Core Needle Biopsy and Needle Localized Breast Biopsy for Mammographically- Detected Breast Lesions Time Commitment: 5% Supporting Agency: Institutional Clinical Resource Management Small Grants Program Award Duration: One year (beginning January 1997; extended to June, 1999) Level of Funding: $10,000 Title: The Effect of Arginine-Enhanced Enteral Nutrition on Tumor-Host Characteristics in Hosts Bearing Nitric Oxide Producing Tumors. Time Commitment: 5% Supporting Agency: Sandoz Nutrition Duration: 4/1/95-3/31/96 Level of Funding: $10,000 Educational Grants Title: A Pilot Study to Examine the Effect of an Objective Structured Clinical Examination (OSCE) on Improving the Acquisition of Clinical Skills in the Third Year Surgery Clerkship. 8
  • 9. CURRICULUM VITAE David Scott Lind, M.D. Time Commitment: Principal Investigator (5%) Supporting Agency: Committee for Education University of Florida Duration: January, 1999 – Jan 2000: Level of Funding: $5,000 Title: A Pilot Study to Develop, Implement and Evaluate an Interdepartmental “Residents as Educators” course at the University of Florida. Time Commitment: Principal Investigator (5%) Supporting Agency: Committee for Education University of Florida Duration: February, 2001 – Jan 2002 Level of Funding: $5,000 Title: Research Training in Surgical Oncology Time Commitment: Co-Principal Investigator (5%) Supporting Agency: National Cancer Institute Duration: 7/1/89-4/30/94 Level of Funding: $346,414 Patents & Copyrights: Interactive Virtual Characters for Medical Diagnosis Training UF # 1147 (Pending) Memberships: Aust Surgical Society 1989–present Association for Academic Surgery 1993–present Eastern Cooperative Oncology Group 1994–2000 Society of Surgical Oncology 1994–present American Society for Parenteral and Enteral Nutrition 1994–1998 Association of VA Surgeons 1995–present Association for Academic Surgery Program Committee 1995–1997 American College of Surgeons, Fellow 1996–present Association for Surgical Education 1997–present Association for Academic Surgery Committee on Education 1997–present Society of University Surgeons 2000-present Florida Surgical Society 2001-present Presentations: Local/Regional Presentations Melanoma: An Epidemic in the Southeast. Huntsville, AL, December 2004. Aligning Primary and Specialty Care: Lessons Learned: VA VISN 8 Ambulatory Care Meeting, Clearwater, Florida, November 2004. The Use of Virtual Characters in Medical Education, University of Florida Education Grand Rounds, September 2004 Competency and New Technology, Florida Surgical Society, Key West June 2004. 9
  • 10. CURRICULUM VITAE David Scott Lind, M.D. ACGME Core Competencies, University of Florida at Jacksonville Surgery Grand Rounds March 2004. The Surgical Management of Melanoma, Valdosta, Georgia, September 2003. Melanoma in the Sunshine State of Florida, Panama City, November 2003. Melanoma: Sentinel Node Biopsy. University of Florida Dermatology Grand Rounds Spring 2004. Melanoma: Sentinel Node Biopsy. University of Florida Dermatology Grand Rounds Spring 2003. Melanoma: Sentinel Node Biopsy. University of Florida Dermatology Grand Rounds Spring 2002. Melanoma: An Epidemic in Florida. University of Florida Dermatology Grand Rounds October 2001. Melanoma: An Epidemic in the Sunshine State. University of Florida Medicine Grand Rounds. Spring 2001. University of Florida Surgery Grand Rounds Virtual Characters in Medical Education, December 1, 2004 Melanoma. November 13, 2004 Competencies: Core and More. March 1, 2004. The Surgery Clerkship 2001-2002: Discussion on Student Education. August 1, 2001. Benign Adrenal Masses. Jan 24, 2001. Hepatic Trauma. August 23, 2000 Surgical Education. July 21,2000 Gastrointestinal Stromal Tumors. December 22,1999 Gastric Cancer. August 21,1999 Lipomatous Tumors. May 19, 1999 Sarcoma and Neurofibromatosis. May 19, 1999 Pleomorphic Adenoma. Feb 24 1999 Gastric Lymphoma. October 21, 1998 Overview of Breast Problems. July 8, 1998 Mediastinal Parathyroid Adenoma. November 12, 1997 Soft Tissue Sarcoma. August 27, 1997 University of Florida Annual Radiation Oncology Symposium Breast Cancer: A Surgical Approach, Spring 2001. Breast Cancer: Sentinel Node Biopsy, Spring 2000. University of Florida Annual Mammography Course (Orlando, Florida) Breast Cancer: Approach to the High Risk Patient, March 2000. Breast Cancer: Sentinel Node Biopsy, March 2000. University of Florida Joint Cancer Conference (Orlando, Florida) Surgical Treatment of Melanoma: Less is More, February 2003. The Sunbelt Melanoma Trial, February 2000. Breast Cancer, February 1998. University of Florida Medical Education Week (Gainesville, Florida) 10
  • 11. CURRICULUM VITAE David Scott Lind, M.D. Competency Based Self-Assessment on a Surgery Rotation, March 2003 Resident as Teachers: The UF Experience, March 2002 National Presentations The Use of Virtual Patients to Teach Medical Students History Taking and Communication Skills, Association for Surgical Education Meeting, New York, NY March 2005. Contemporary Management of Benign Breast Disease, American College of Surgeons Meeting, New Orleans, LA, October 2004. Melanoma in the North Florida/South Georgia Veteran Health System: Advanced Depth and Stage at Presentation. Presented at the VA Surgeons Meeting, Nashville, TN May 2003. Breast Cancer Testing:Too Much or Too Little-What is Appropriate ? Society of Surgical Oncology, Denver, March 2002. Breast Cancer: Screening. Eastern Virginia Medical School Breast Cancer Symposium, September 2001. NF-kB is Upregulated in Colorectal Cancer. Society of University Surgeons Meeting, February 2001 Postmastectomy Radiation: A Debate. Society of Surgical Oncology Meeting, March 2000 Copeland EM III. Breast Cancer: Case Presentations. American College of Surgeons Meeting, October 1999. Breast Cancer: The University of Florida Experience, Eastern Virginia Medical School Alumni Re-union Symposium, August 1999 Breast Cancer: Management of the Axilla in 1999. Society of Surgical Oncology Meeting, March 1999 The Effect of the Duration and Structure of a Surgery Clerkship on Student Performance. Plenary Session, Association for Academic Surgery Meeting, November 1998. Breast Cancer: The University of Florida Experience. Halsted Society, Fall 1998. Gender-Specific Differences on an OSCE Breast Station, Association for Surgical Education Meeting, April 2001 Intraoperative Assessment of Sentinel Lymph Nodes in Breast Cancer, Society of Breast Diseases Meeting, Spring 2001. Publications: 1. Lind DS, McGrath PC: Cervical lymph node metastasis of unknown primary. Postgrad Gen Surg 2: 241–244, December, 1990. 2. Susskind BM, Sekar J, Mehrotra P, Lind DS, Bear HD: Differential sensitivity of cytotoxic T lymphocytes and lymphokine–activated killer cells to inhibition by ornithine. Cell Immunol 133: 41–54, 1991. 3. Kahky M, Lind DS, Cruz AB, Gaskill HV: Prostaglandin E1 enhances the tumoricidal activity of flouro–5–deoxyuridine. J Surg Res 51: 119–123, 1991. 4. Lind DS, Adolph V, Parker GA: Mucinous biliary cystadenoma – a case report and review of the literature. J Surg Oncol 51: 207–210, 1992. 11
  • 12. CURRICULUM VITAE David Scott Lind, M.D. 5. Lind DS, Parker GA, Horsley JS, et al.: Formal hepatic resection of colorectal liver metastases. Ann Surg 215: 677–684, 1992. 6. Mehrotra P, Lind DS, Bear HD, Susskind BM: Different signaling pathways induced by α–CD3 monoclonal antibody versus alloantigen on the basis of differential ornithine sensitivity. Cellular Immunology 143(1): 41–54, 1992. 7. Tuttle T, Lind DS, Bear HD: Adoptive transfer of bryostatin 1–activated T cells provides long–term protection from tumor metastases. Surg Oncol. 1(4): 299–307, 1992. 8. Lind DS, Copeland EM, Souba WW: Endotoxin stimulates arginine transport in pulmonary artery endothelial cells. Surgery 114(2): 199–205, 1993. 9. Cendan JC, Lind DS, Copeland EM, Souba WW: Cytokines regulate endotoxin stimulation of endothelial cell arginine transport. Surgery 117: 213–219, 1995. 10.Lind DS, Tuttle TM, Bethke KB, et al.: Expansion and tumor specific cytokine secretion of bryostatin–activated T–cells from cryopreserved axillary lymph nodes of breast cancer patients. Surg Oncol. 2(5): 273–282, 1993. 11.Frank JL, Garb JL, Kay S, McClish DK, Bethke KP, Lind DS, et al.: Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg 168: 476–480, 1994. 12.Espat NJ, Hocking MP, Drane WE, Fagien M, Lind DS: Technetium–labelled red blood cell scan: a useful test when employed appropriately. (Presented to the Southeastern Surgical Society meeting, January 1994) 13.Cendan JC, Lind DS, Bland KI, Copeland EM: Predictors of residency performance and career choice: review of the University of Florida residency program 1983–1993. (Presented to the Association of Program Directors Meeting, March 1994). 14.Cendan JC, Moldawer LL, Souba WW, Copeland EM III, Lind DS: Endotoxin–induced nitric oxide production in pulmonary artery endothelial cells is regulated by cytokines. Arch Surg 129: 1296–1300, 1994. 15.Marsh R, Chu NM, Mendenhall W, Vauthey JN, Copeland EM, Lind DS. Neoadjuvant circadian–shaped 5–FU infusion plus radiation for locally advanced rectal cancer. (Abstract submitted to the American Society of Clinical Oncology Meeting, May 1995). 16.Cendan JC, Souba WW, Copeland EM III, Lind DS: Characterization and growth factor stimulation of L–arginine transport in a human colon cancer cell line. Ann Surg Oncol 2(3): 257–265; 1995 12
  • 13. CURRICULUM VITAE David Scott Lind, M.D. 17.Espat NJ, Lind DS, Copeland EM III, Souba WW: Normalization of tumor–induced increases in hepatic amino acid transport after surgical resection. Ann Surg 221(1): 50–58, 1995. 18.Lind DS, Cendan JC, Copeland EM, Souba WW: Nutrition for the cancer patient. Contemporary Surgery 47(1): 17–23, 1995 19. Pan M, Wasa Y, Lind DS, Gertler J, Abbott W, Souba WW: TNF–stimulated arginine transport by human vascular endothelium requires activation of protein kinase C. Ann Surg 221(5): 590–601, 1995. 20. Cendan JC, Souba WW, Copeland EM III, Lind DS: Increased transport in a nitric oxide–producing metastatic colon cancer cell line. Ann Surg Oncol 3(5): 501–508, 1996. 21.Vauthey JN, Dudrick PS, Lind DS, Copeland, EM III: Management of recurrent colorectal cancer: Another look at carcinoembryonic antigen–detected recurrence. Dig Dis 14: 5– 13, 1996. 22. Cendan JC, Topping DL, Pruitt J, Snowdy S, Copeland EM, Lind DS: Inflammatory mediators stimulate arginine transport and arginine–derived nitric oxide production in a murine breast cancer cell line. J Surg Research 60(2): 284–288, 1996. 23.Edwards P, Cendan JC, Topping DS, Moldawer, LL, MacKay SLD, Copeland, EM III, Lind, DS: Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Research 63: 49–62, 1996. 24.Espat NJ, Watkins KT, Lind DS, Weis JK, Copeland EM, Souba WW: Dietary modulation of amino acid transport in rat and human liver. J Surg Research 63: 263– 268, 1996. 25. Lind DS, Kontaridis MI, Edwards PD, Moldawer LL, Copeland EM. Nitric oxide contributes to adriamycin’s anti-tumor effect. J Surg Research 69:283–287, 1998. 26.Edwards PD, Topping D, Kontaridis MI, Moldawer LL, Copeland EM III, Lind, DS. Arginine enhanced enteral nutrition augments the growth of a nitric oxide–producing tumor. JPEN 21(4):215–219, 1998. 28. Josephs M, Rekkas D, Kontaridis MI, Moldawer LL, Copeland EM III, Lind DS. Adriamycin’s cytotoxicity is partially mediated by tumor necrosis factor (TNF) and is attenuated by TNF-binding protein (TNF-BP). (Abstract presented at the Society of University Surgeons meeting November 1998). 29.Lind DS, Minter R, Steinbach B, Abbitt P, Lanier L, Haigh L, Vauthey JN, Copeland EM III. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Research 78:23–26, 1998 13
  • 14. CURRICULUM VITAE David Scott Lind, M.D. 30.Lind, DS. Radioisotope–guided imagery (guest reviewer). Cur Surg 55(6):1998 31.Lind DS. Current surgical management of melanoma. University of Florida Cancer Annual Report. 1999. 32.Abdalla EK, Flynn TC, Copeland EM, Lind DS. The effect of a breast service on resident performance of breast disease–related ABSITE items. Presented to the Florida Surgical Society Meeting, July 1998. The Breast Journal 6(3):157-160, 2000. 33.Lind DS, Marum T, Ledbetter D, Flynn TC, Copeland EM III. The effect of the structure of a surgery clerkship on student performance. J Surg Res 84(1):106-111, 1999. 34.Minter B, Topping D, Copeland EM, Lind DS. An institutional validation of breast cancer treatment algorithms. J. Surg Res. 78(1):23-28, 1998. 35.Mishra G, Lawyers G, Braylan R, Lind DS, Lynch J. Endoscopic Ultrasound (EUS): an underutilized tool in the mmanagement of MALT. Gastrointest Endosc 49:210-212, 1999. 36.Lind DS, Hebig P, Rekkas S, Moldawer LL, Copeland EM. Chemotherapy upregulates NF-kB in a breast cancer cell line. (Abstract presented to the Association for Academic Surgery Meeting in November 2000.) 37.MacKay SLD, Malaty J, Peters K, Tannahill, Abouhamze Z, Fukuzuka K, Bahjat FR, Moldawer LL, Copeland EM, Lind DS. Aberrant activation of nuclear factor kappaB in colon cancer. Manuscript submitted to Oncogene October 2000. 38.Lind DS, Hebig P, Rekkas S, MacKay S, Hochwald S, Moldawer LL, Copeland EM. NF- kB is upregulated in colorectal cancer. Abstract presented to o the Society of University Surgeons Meeting in February 2001. Surgery April 2001. 39.Brown HM, Lind DS, Wilkinson EJ. Intraoperative Assessment of Sentinel Lymph Nodes in Breast Cancer. Abstract accepted to the American College of Pathology Meeting Spring 20001 40.Lind DS. Editorial on: Hook GW, Ikeda DM. Treatment of breast abscesses with US- guided percutaneous needle drainage without indwelling catheter placement. Radiology 213:579-582, 1999. In: Breast Diseases 11(3): 314-315 Oct-Dec 2000. 41.Lind DS. Editorial on: Abdalla EK, Flynn TC, Copeland EM, Lind DS. The effect of a breast service on resident performance of breast disease–related ABSITE items. Presented to the Florida Surgical Society Meeting, July 1998. The Breast Journal 6(3):157-160, 2000. 14
  • 15. CURRICULUM VITAE David Scott Lind, M.D. 42.Walker S, Duerson M, Lind DS. Gender-Specific Differences on an OSCE Breast Station. Abstract submitted to the Association for Surgical Education Meeting March 2001. 43.Mendenhall WM, Morris CG, Rout RW, Zlotecki RA, Lind DS, Hochwald SN, Copeland EM. Local excision and postoperative radiation therapy for rectal adenocarcinomas. Manuscript accepted for publication in Cancer June 2001. 44.Kamath SS, Mendenhall NP, Moore-Higgs GJ, Lind DS, Copeland EM. The relative impact of the extent of axillary dissection and regional nodal radiotherapy on the development of arm edemain early-stage breast cancer treated with breast-conserving therapy. Manuscript submitted to the International Journal Radiation Oncology Biological Physics, May 2001. 45.Mendenhall WM, Rout RW, Lind DS, Zlotecki RA, Hochwald SN, Copeland EM. The role of radiation therapy in the treatment of resectable rectal adenocarcinoma. Manuscript submitted to the Journal of Surgical Oncology, August 2001. 46.Lind DS, Rekkas S, Bui V, Lam T, Beierle E, Copeland EM. Competency-based student self-assessment on a surgery rotation. J. Surg. Res. 105:31-34, 2002 47.Feezor R, Kasraeian A, Copeland EM III, Schell S, Hochwald S, Drane W, Mastin S, Wilkinson E, Lind DS. Sequential dermal-peritumoral radiocolloid injection for sentinel lymph node (SLN) biopsy in breast cancer. Am Surg 68:684-687, 2002. 48.Camp R, Lind DS, Hemming A. Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma. J Hepatobiliary Pancreat Surg. 9:519-521, 2002. 49.Schell SR, Lind DS, Flynn TC. Graduated competency assessment: An internet-based tool for measuring surgical resident competency, J Surg Res 107(2):304, 2002. 50.Lind DS, Schell SR. An internet-based tool for evaluating third year medical student performance. Am. J. Surg. :211-215, 2003. 51.Zlotecki RA, Scarborough MT, Morris CG, Berrey BH, Lind DS, Enneking WF, Marcus RB Jr. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 54(1):177-181, 2002. 52.Lind DS. Breast cancer testing: what is appropriate ? J Surg Oncol 81:111-112, 2002. 53.Benda RK, Cendan JC, Copeland EM, Feezor RJ, Lind DS, Morris CG, Mendenhall NP. Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification? Cancer. Feb 1;100(3):518-23, 2004. 15
  • 16. CURRICULUM VITAE David Scott Lind, M.D. 54.Benda RK, Mendenhall NP, Lind DS, Cendan JC, Shea BF, Richardson LC, Copeland EM 3rd. Breast-conserving therapy (BCT) for early-stage breast cancer. J Surg Oncol. Jan;85(1):14-27, 2004. 55.Benda RK, Mendenhall NP, Lind DS, Cendan JC, Shea BF, Richardson LC, Copeland EC. Breast-conserving therapy for early-stage breast cancer. J. Surg. Onc. 85(1): 14- 27, 2004. 56.Camp ER, Cendan JC, Feezor R, Lind DS, Wilkinson E, Copeland EM. The hottest sentinel lymph node is not always the positive node. Am Surg. 2004 Jun;70(6):475-8; discussion 478. 57.Benda RK, Mendenhall NP, Lind DS, Cendan JC, Shea BF, Richardson LC, Copeland EM 3rd. Breast-conserving therapy (BCT) for early-stage breast cancer. J Surg Oncol. 2004 Jan;85(1):14-27. 58.Lind DS. Arginine and Cancer. J. Nutr. 2004 Oct;134 (10 Suppl):2837S-2841S; discussion 2853S. Review. 59.Camp ER, Gilroy J, Lind DS, Morris CG, Mendenhall N, Copeland EM. Frozen section analysis of shaved margins for breast conservation: a single surgeons experience. Abstract presented to the Society of Surgical Oncology meeting March 2004. 60.Camp ER Cendan JC Lind DS. Nipple Discharge: A case report and literature review (Submitted to the Breast Journal). 61.Camp ER, Feezor RJ, Kasraeian A, Cendan JC, Schell S, Wilkinson E, Copeland EM, Lind DS. Sentinel Lymph Node (SLN) Biopsy for DCIS: An evolving approach at the University of Florida. (Submitted to the Breast Journal). 62.Johnsen K, Dickerson R, Raji A, Lok B, Jackson J, Shin M, Hernandez J, Stevens, A Lind DS. Experiences in using immersive virtual characters to educate medical communication skills. Abstract accepted to the Institute of Electrical and Electronics Engineers (IEEE) Virtual Reality Conference, Bonn, Germany, March 2005. 63.Chisholm K, Zingarelli W, Lind DS, Brown D, Stevens AO. The use of a simulation- based training program to shorten wait times for lower GI tract endoscopies and improve patient outcomes in the North Florida South Georgia VA Health System. Abstract submitted to the VA Surgeons meeting, Salt Lake City, UT, March 2005. 64.Stevens A, Hernandez J, Johnsen K, Dickerson R, Raij A, Jackson J, Min Shin, Cendan JC, Duerson M, Lok B, Lind DS. The use of virtual patients to teach medical students communication skills. Submitted to Am. J. Surg., April 2005. 65.Camp ER, Schell S, Chisholm K, Rekkas S, Dean S, Lind DS. Melanoma in the North Florida South Georgia Veterans Health System: Advanced Depth & Stage at Presentation. Manuscript (submitted to the Journal of Surgical Oncology, April 2005). 16
  • 17. CURRICULUM VITAE David Scott Lind, M.D. Book Chapters 1. Lind DS: Gastric cancer. In: Surgical Attending Rounds, Dyke CM, Lee KF (editors), 1992, Lee & Febiger, Philadelphia, PA. 2. Lind DS, Souba WW, Copeland EM: Weight loss and cachexia. In: Clinical Oncology, Abeloff ME, Armitage JO, Lichter AS, Niederhuber JE (editors), 1995, Churchill– Livingstone, New York, NY. 3. Lind DS, Souba WW: Neoplastic diseases of the colon and rectum. In: Digestive Tract Surgery, A Text and Atlas, Bell RH, Rikkers LF, Mulholland MW (editors), 1996, J. B. Lippincott, Philadelphia, PA, pp. 1387–1403. 4. Copeland EM, Lind DS. Tratamiento del cáncer de mama en los estadios I y II. In: Actualización en Cirugía del Aparato Digestivo, González EM, Pascual MH (editors), 1996, Jarpyo Editores, Madrid, Vol. IX, pp. 543–546. 5. Lind DS, Souba WW, Copeland EM: Nutrition as an adjunct in patients with cancer. In: Nutrition and Surgery, Lafiti R, Dudrick SJ (editors), Mosby Year Book, St. Louis, MO (in press). 6. Lind DS, Copeland EM: Special problems related to the operative site: local recurrence, the augmented breast and the contralateral breast. In: The Breast, 3nd edition, Bland KI (editor), W.B. Saunders, Philadelphia, PA. November 2003. 6. Lind DS, Copeland EM: Management of complications after mastectomy and breast conservation therapy. In: Problems in General Surgery, Radford DM (editor), Lippincott-Raven, New York, NY. 1996; Vol. 13, pps 56–63. 7. Lind DS, Copeland EM: Breast–conserving therapy. In: Breast Pathology Treaty and Manual, Basurto CS (editor), Mexican Academy of Surgery, Mexico 1998. 8. Lind DS and Vogel SB. Gastric Neoplasms. In: Surgical Oncology: Contemporary Principles and Practice. Bland KI, Daly JM, Karakousis CP (editors) McGraw-Hill Co.2001. 9. Lind DS. Diseases of the Breast. In: Conn’s Current Therapy. Rakel RE, Bope ET (editors) W.B. Saunders, Philadelphia 2005. 10. Lind DS, Smith BL, Souba WW. Breast Complaints. In: American College of Surgeons (ACS) Surgery: Principles and Practice, Wilmore DW, Souba WW (editors), Web MD Corporation, New York NY. (In Press). 11. Lind DS, Smith BL, Souba WW. Breast Procedures. In: American College of Surgeons (ACS) Surgery: Principles and Practice, Wilmore DW, Souba WW (editors), Web MD Corporation, New York NY. (In Press). 17
  • 18. CURRICULUM VITAE David Scott Lind, M.D. Revised: 1/29/15 18

×